Newly Approved Oral Medication Slows Rheumatoid Arthritis Joint Damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis patients who did not respond to methotrexate .
Join the discussion below, or Read more at MediLexicon.
Since: Jan 13
#1 Jan 25, 2013
This could be great information for arthritis people.Thanks for information.
#2 Apr 1, 2013
Wow this is amazing if it really slows down the effects of arthritis. I have read somewhere at depuypinnaclelawsuit. com that there may be some preoblems with hip replacements so this is a new alternative.
Add your comments below
|Study: Compound in Green Tea Could Help Fight R...||Feb '16||ANN||1|
|Men With Rheumatoid Arthritis Have Increased Ri... (Sep '12)||Jan '16||Lore||18|
|Baptism by Radon: Cure for Erectile Dysfunction... (Aug '12)||Jan '16||Quattrone||13|
|HLA-B27 Positive/Negative inflamation tests/chr...||Jan '16||TestQuestion||1|
|What is a urologist? What do urologists do? (Dec '14)||Jan '16||pailrider||67|
|Patients grapple with high cost of arthritis me... (Apr '15)||Jul '15||Walnut Fruitcake||2|
|I'm a board certified Rheumatologist but curren... (Sep '14)||May '15||jaris280||3|
Find what you want!
Search Rheumatology Forum Now
Copyright © 2016 Topix LLC